Blog

BrainStorm gets FDA fast-track status for ALS stem cell therapy – Raw Story


Raw Story

BrainStorm gets FDA fast-track status for ALS stem cell therapy
Raw Story
Israel's BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration has designated its adult stem cell treatment as a “fast-track” product for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm's treatment, called NurOwn, is …
Brainstorm's Stem Cell Based Drug NurOwn Gets FDA Fast Track ApprovalJewish Business News



all 28 news articles »

2014-10-07 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.